Company: NCEL
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026428
Chunk: 193

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: F-4/A
Chunk 193
---
 share unit, restricted share, warrant or other rights issued and outstanding, whether vested or unvested, to purchase Kadimastem Ordinary Shares, shall be assumed by NLS and converted into an option, warrant, other award, or right, as applicable, to purchase NLS Common Shares in accordance with the terms of the Merger Agreement. Additional information regarding conditional share capitals is set forth below in the section entitled “Conditional Share Capital” and in the proxy statement. Please also see “ Preliminary Proxy Statement, Subject To Completion — Notice Of Extraordinary Meeting Of Shareholders To Be Held On , [2025] — 6. Conditional Share Capital for Shareholders’ Options” of this proxy statement/prospectus. To approve Proposal6, a resolution passed by a Supermajority Vote is required. You may vote “FOR,” “AGAINST” or “ABSTAIN” on Proposal 6. A failure to vote, an abstention or a broker non -vote, if any, will have the same effect as a vote “AGAINST” Proposal 6. THE NLS BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE
“FOR” PROPOSAL 6. 83 APPROVAL OF THE TRANSFER AND VOTING RIGHTS LIMITATION OF 9.99%, GRANTING THE BOARD DISCRETION TO PROVIDE FOR EXCEPTIONS (ARTICLE 6 OF THE ARTICLES) (PROPOSAL 7) Due to the transactions contemplated by and in connection with the Merger, a limitation on exercisable voting rights is intended to be introduced in the Company’s articles of association. Accordingly, shareholders shall only be able to (directly or indirectly) hold, and exercise voting rights for, a maximum of 9.99% of the share capital of the Company at any one time. To effect this, the provisions on the entry of shareholders into the share register as well as the provisions on the voting rights is intended to be amended. This amendment ensures that no sole shareholder may gain a controlling voting majority in the Company without the Board of Directors (indirectly) approving such majority by approving the relevant entry of such a shareholder in the share register. The Board of Directors is of the opinion that such a limitation is in the best interest of the Company. To approve Proposal7, a resolution passed by a Supermajority Vote is required. You may vote “FOR,” “AGAINST” or “ABSTAIN” on Proposal 7. A failure to vote, an abst